Before revision:  To develop CLEAR, we compared DEGs from RNA extracted from FACS-derived CD5+ and CD5- cells from a single chronic lymphocytic leukemia patient diluted to input RNA levels of 10-, 100- and 1,000pg.
After revision:  To develop CLEAR, we compared DEGs from RNA extracted from FACS-derived CD5+ and CD5- cells from a chronic lymphocytic leukemia patient diluted to input RNA levels of 10-, 100- and 1,000pg.